Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001520711-18-000002
Filing Date
2018-06-26
Accepted
2018-06-25 20:15:52
Documents
1
Effectiveness Date
2018-06-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7924
  Complete submission text file 0001520711-18-000002.txt   9083
Mailing Address 5871 OBERLIN DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 224-7700
Mistral Therapeutics, Inc. (Filer) CIK: 0001520711 (see all company filings)

EIN.: 275081482 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-315373 | Film No.: 18918095